Oncotype DX cancer testing
Senator Keane praises the Oncotype DX test for avoiding unnecessary chemotherapy and saving HSE funds, while also welcoming improved appointment management.
I want to get on to the positive news that was announced yesterday. The use of the Oncotype DX cancer test, in the cases of 300 people, has saved the HSE €856,000 in one year. Ireland was the first country in Europe to use this test to elucidate whether cancer patients need chemotherapy. Approximately 50% of women who were tested avoided the need for chemotherapy. It has saved lives. Senators know what people go through when they are subjected to chemotherapy. Irish patients are more likely to benefit from early chemotherapy and hormonal treatment as a result of the use of this test. Ireland was the first country in Europe to use it. The first result was announced yesterday by the Minister, Deputy Reilly. He congratulated the doctors who were involved. He advised that this be used more widely. Senator Kelly spoke about patients who have been sent three or four letters. That is a bad waste of money. A new system, whereby patients can be texted, is coming on stream. Many patients do not turn up for appointments. They waste hospital money. The Minister is trying to redress this.
Comment on this
The HSE obviously loses money when people do not turn up. It is trying to make sure they turn up.
Comment on this
There is bad management as well.
Comment on this
Absolutely. I agree. I hope the new texting system will counteract all of that. The other good news is that the practice of giving 30 or 40 patients appointments for the same time - 11 a.m, for example - is to be ended.
That is a waste of people's money and is bad management, and it is changing as well. I agree with Senator Norris-----